{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:45:57Z","timestamp":1791146757962,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1038\/sj.bjc.6601112","type":"journal-article","created":{"date-parts":[[2003,8,12]],"date-time":"2003-08-12T18:10:57Z","timestamp":1060711857000},"page":"713-719","source":"Crossref","is-referenced-by-count":42,"title":["Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation"],"prefix":"10.1038","volume":"89","author":[{"given":"W","family":"Klapper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Krams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Parwaresch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,8,12]]},"reference":[{"key":"BF6601112_CR1","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1073\/pnas.94.25.13677","volume":"94","author":"CD Belair","year":"1997","unstructured":"Belair CD, Yeager TR, Lopez PM, Reznikoff CA (1997) Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677\u201313682","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6601112_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/350569a0","volume":"350","author":"EH Blackburn","year":"1991","unstructured":"Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569\u2013573","journal-title":"Nature"},{"key":"BF6601112_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1006\/bbrc.1998.9674","volume":"253","author":"G Bonatz","year":"1998","unstructured":"Bonatz G, Klapper W, Barthe A, Heidorn K, Jonat W, Krupp G, Parwaresch R (1998) Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium. Biochem Biophys Res Commun 253: 214\u2013221","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6601112_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood.V89.1.26","volume":"89","author":"P Brousset","year":"1997","unstructured":"Brousset P, al Saati T, Chaouche N, Zenou RC, Schlaifer D, Chittal S, Delsol G (1997) Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood 89: 26\u201331","journal-title":"Blood"},{"key":"BF6601112_CR5","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1002\/j.1460-2075.1995.tb00098.x","volume":"14","author":"TM Bryan","year":"1995","unstructured":"Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240\u20134248","journal-title":"EMBO J"},{"key":"BF6601112_CR6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1091\/mbc.7.9.1443","volume":"7","author":"KJ Buchkovich","year":"1996","unstructured":"Buchkovich KJ, Greider CW (1996) Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 7: 1443\u20131454","journal-title":"Mol Biol Cell"},{"key":"BF6601112_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.onc.1205063","volume":"21","author":"DR Corey","year":"2002","unstructured":"Corey DR (2002) Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 21: 631\u2013637","journal-title":"Oncogene"},{"key":"BF6601112_CR8","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1093\/emboj\/20.24.6958","volume":"20","author":"K Damm","year":"2001","unstructured":"Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A (2001) A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 20: 6958\u20136968","journal-title":"EMBO J"},{"key":"BF6601112_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/82586","volume":"26","author":"MA Dunham","year":"2000","unstructured":"Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere maintenance by recombination in human cells. Nat Genet 26: 447\u2013450","journal-title":"Nat Genet"},{"key":"BF6601112_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1097-0142(20000715)89:2<445::AID-CNCR33>3.0.CO;2-T","volume":"89","author":"SA Ely","year":"2000","unstructured":"Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM (2000) Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer 89: 445\u2013452","journal-title":"Cancer"},{"key":"BF6601112_CR11","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/sj.onc.1202669","volume":"18","author":"RA Greenberg","year":"1999","unstructured":"Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18: 1219\u20131226","journal-title":"Oncogene"},{"key":"BF6601112_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0092-8674(00)80760-6","volume":"97","author":"JD Griffith","year":"1999","unstructured":"Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, De Lange T (1999) Mammalian telomeres end in a large duplex loop. Cell 97: 503\u2013514","journal-title":"Cell"},{"key":"BF6601112_CR13","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.93.13.6476","volume":"93","author":"C Harle-Bachor","year":"1996","unstructured":"Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476\u20136481","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6601112_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood.V90.1.226","volume":"90","author":"HJ Heidebrecht","year":"1997","unstructured":"Heidebrecht HJ, Buck F, Steinmann J, Sprenger R, Wacker HH, Parwaresch R (1997) p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood 90: 226\u2013233","journal-title":"Blood"},{"key":"BF6601112_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/emboj\/19.3.472","volume":"19","author":"E Herrera","year":"2000","unstructured":"Herrera E, Martinez A, Blasco MA (2000) Impaired germinal center reaction in mice with short telomeres. EMBO J 19: 472\u2013481","journal-title":"EMBO J"},{"key":"BF6601112_CR16","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1126\/science.1069523","volume":"295","author":"J Karlseder","year":"2002","unstructured":"Karlseder J, Smogorzewska A, De Lange T (2002) Senescence induced by altered telomere state, not telomere loss. Science 295: 2446\u20132449","journal-title":"Science"},{"key":"BF6601112_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011\u20132015","journal-title":"Science"},{"key":"BF6601112_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0167-4781(98)00155-9","volume":"1442","author":"W Klapper","year":"1998","unstructured":"Klapper W, Singh KK, Heidorn K, Parwaresch R, Krupp G (1998) Regulation of telomerase activity in quiescent immortalized human cells. Biochim Biophys Acta 1442: 120\u2013126","journal-title":"Biochim Biophys Acta"},{"key":"BF6601112_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s001090050085","volume":"75","author":"AJ Klingelhutz","year":"1997","unstructured":"Klingelhutz AJ (1997) Telomerase activation and cancer. J Mol Med 75: 45\u201349","journal-title":"J Mol Med"},{"key":"BF6601112_CR20","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0002-9440(10)63039-8","volume":"159","author":"M Krams","year":"2001","unstructured":"Krams M, Claviez A, Heidorn K, Krupp G, Parwaresch R, Harms D, Rudolph P (2001) Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am J Pathol 159: 1925\u20131932","journal-title":"Am J Pathol"},{"key":"BF6601112_CR21","first-page":"3","volume":"142","author":"H Kreipe","year":"1993","unstructured":"Kreipe H, Heidebrecht HJ, Hansen S, Rohlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R (1993a) A new proliferation-associated nuclear antigen detectable in paraffin- embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol 142: 3\u20139","journal-title":"Am J Pathol"},{"key":"BF6601112_CR22","first-page":"1689","volume":"142","author":"H Kreipe","year":"1993","unstructured":"Kreipe H, Wacker HH, Heidebrecht HJ, Haas K, Hauberg M, Tiemann M, Parwaresch R (1993b) Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 142: 1689\u20131694","journal-title":"Am J Pathol"},{"key":"BF6601112_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/PL00000708","volume":"57","author":"G Krupp","year":"2000","unstructured":"Krupp G, Klapper W, Parwaresch R (2000) Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. Cell Mol Life Sci 57: 464\u2013486","journal-title":"Cell Mol Life Sci"},{"key":"BF6601112_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/nar\/25.4.919","volume":"25","author":"G Krupp","year":"1997","unstructured":"Krupp G, Kuhne K, Tamm S, Klapper W, Heidorn K, Rott A, Parwaresch R (1997) Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust \u2018TRAP\u2019 assay. Nucleic Acids Res 25: 919\u2013921","journal-title":"Nucleic Acids Res"},{"key":"BF6601112_CR25","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","volume":"341","author":"R Kuppers","year":"1999","unstructured":"Kuppers R, Klein U, Hansmann ML, Rajewsky K (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341: 1520\u20131529","journal-title":"N Engl J Med"},{"key":"BF6601112_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/nar\/28.3.669","volume":"28","author":"S Kyo","year":"2000","unstructured":"Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28: 669\u2013677","journal-title":"Nucleic Acids Res"},{"key":"BF6601112_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9440(10)61742-7","volume":"159","author":"Z Lin","year":"2001","unstructured":"Lin Z, Lim S, Viani MA, Sapp M, Lim MS (2001) Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol 159: 711\u2013719","journal-title":"Am J Pathol"},{"key":"BF6601112_CR28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/blood.V88.1.222.222","volume":"88","author":"KF Norrback","year":"1996","unstructured":"Norrback KF, Dahlenborg K, Carlsson R, Roos G (1996) Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88: 222\u2013229","journal-title":"Blood"},{"key":"BF6601112_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1034\/j.1600-0609.2001.00588.x","volume":"67","author":"KF Norrback","year":"2001","unstructured":"Norrback KF, Hultdin M, Dahlenborg K, Osterman P, Carlsson R, Roos G (2001) Telomerase regulation and telomere dynamics in germinal centers. Eur J Haematol 67: 309\u2013317","journal-title":"Eur J Haematol"},{"key":"BF6601112_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s004120050354","volume":"108","author":"ML Pardue","year":"1999","unstructured":"Pardue ML, Debaryshe PG (1999) Telomeres and telomerase: more than the end of the line. Chromosoma 108: 73\u201382","journal-title":"Chromosoma"},{"key":"BF6601112_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1054\/bjoc.1999.0970","volume":"82","author":"K Remes","year":"2000","unstructured":"Remes K, Norrback KF, Rosenquist R, Mehle C, Lindh J, Roos G (2000) Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 82: 601\u2013607","journal-title":"Br J Cancer"},{"key":"BF6601112_CR32","first-page":"450","volume":"11","author":"P Rudolph","year":"1998","unstructured":"Rudolph P, Knuchel R, Endl E, Heidebrecht HJ, Hofstader F, Parwaresch R (1998) The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen. Mod Pathol 11: 450\u2013456","journal-title":"Mod Pathol"},{"key":"BF6601112_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0960-9822(00)00752-1","volume":"10","author":"S Smith","year":"2000","unstructured":"Smith S, De Lange T (2000) Tankyrase promotes telomere elongation in human cells. Curr Biol 10: 1299\u20131302","journal-title":"Curr Biol"},{"key":"BF6601112_CR34","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1128\/MCB.20.5.1659-1668.2000","volume":"20","author":"A Smogorzewska","year":"2000","unstructured":"Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, De Lange T (2000) Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659\u20131668","journal-title":"Mol Cell Biol"},{"key":"BF6601112_CR35","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1093\/emboj\/20.19.5532","volume":"20","author":"RM Stansel","year":"2001","unstructured":"Stansel RM, De Lange T, Griffith JD (2001) T-loop assembly in vitro involves binding of TRF2 near the 3\u2032 telomeric overhang. EMBO J 20: 5532\u20135540","journal-title":"EMBO J"},{"key":"BF6601112_CR36","first-page":"4168","volume":"58","author":"GA Ulaner","year":"1998","unstructured":"Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58: 4168\u20134172","journal-title":"Cancer Res"},{"key":"BF6601112_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/385740a0","volume":"385","author":"B van Steensel","year":"1997","unstructured":"van Steensel B, De Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385: 740\u2013743","journal-title":"Nature"},{"key":"BF6601112_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0092-8674(00)80932-0","volume":"92","author":"B van Steensel","year":"1998","unstructured":"van Steensel B, Smogorzewska A, De Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401\u2013413","journal-title":"Cell"},{"key":"BF6601112_CR39","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1101\/gad.12.12.1769","volume":"12","author":"J Wang","year":"1998","unstructured":"Wang J, Xie LY, Allan S, Beach D, Hannon GJ (1998) Myc activates telomerase. Genes Dev 12: 1769\u20131774","journal-title":"Genes Dev"},{"key":"BF6601112_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/clim.1999.4741","volume":"92","author":"N Weng","year":"1999","unstructured":"Weng N (1999) Telomeres, telomerase, and lymphocyte replicative life span. Clin Immunol 92: 1\u20132","journal-title":"Clin Immunol"},{"key":"BF6601112_CR41","doi-asserted-by":"publisher","first-page":"10827","DOI":"10.1073\/pnas.94.20.10827","volume":"94","author":"NP Weng","year":"1997","unstructured":"Weng NP, Granger L, Hodes RJ (1997) Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 94: 10827\u201310832","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6601112_CR42","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1084\/jem.183.6.2471","volume":"183","author":"NP Weng","year":"1996","unstructured":"Weng NP, Levine BL, June CH, Hodes RJ (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183: 2471\u20132479","journal-title":"J Exp Med"},{"key":"BF6601112_CR43","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1073\/pnas.071043198","volume":"98","author":"D Xu","year":"2001","unstructured":"Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M (2001) Switch from Myc\/Max to Mad1\/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci USA 98: 3826\u20133831","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6601112_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1126\/science.289.5480.771","volume":"289","author":"J Zhou","year":"2000","unstructured":"Zhou J, Monson EK, Teng S, Schulz VP, Zakian VA (2000) Pif1p helicase, a catalytic inhibitor of telomerase in yeast. Science 289: 771\u2013774","journal-title":"Science"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:51:13Z","timestamp":1684414273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF6601112"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601112","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}